International bank for foot-and-mouth disease vaccine: Assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants

Vaccine

Volumn 14, Issue 13, 1996, Pages 1187-1198

  Barnett, P V ^a   Pullen, L ^a   Williams, L ^a   Doel, T R ^a,b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Rhône Mérieux Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; IMMUNOLOGICAL ADJUVANT; MONTANIDE ISA 206; MONTANIDE ISA 25; OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG STABILITY; FOOT AND MOUTH DISEASE; GUINEA PIG; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; APHTHOVIRUS; CATTLE; SWINE; VACCINATION; VIRAL VACCINES;

EID: 0030250764     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00055-2     Document Type: Article

References (35)

1. 1 Doel T.R., Williams L., Barnett P.V. (1994) Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12, 592-600
2. 2 Donaldson A.I., Doel T.R. (1992) Foot-and-mouth disease: the risk for Great Britain after 1992. Vet. Rec. 131, 114-120
3. 3 van Bekkum J.G., Bool P.H., Vermeulen C.J. (1967) Experience with the vaccination of pigs for the control of foot-and-mouth disease in the Netherlands. Tijdschr Diergeneeskd 92Suppl. 1, 87-97
4. 4 Nathans, I. Vaccinatie van varkens tegen mond-en klauwzeer met geinactiveerd virus bevattende entstoffen, Thesis, Utrecht, 1965
5. 5 Leeuw P.W., de Tiessink J.W.A., Frenkel S. (1979) Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D). Zentrabl. Vet. Med. B. 26, 85-97
6. 6 Wittmann G. (1970) Die Verwendung von Diethyamino-aethyl-Dextran (DEAE-D) als Adjuvants bei der Immunisierung von Meerschweinchen mit inaktivierten Maul-und-Klauenseuche (MKS)-Viren. Zentrabl. Bakteriol. 1 Orig. 213, 1-8
7. 7 Wittmann G. (1972) Versuche zur Revakzinierung von Schweinen mit einer Athylathylenimin (EEI)/DEAE-Dextran-Vakzine gegen Maul-und-Klauenseuche. Zentrabl. Vet. Med. B. 19, 45-54
8. 8 Anderson E.C., Masters R.C., Mowat G.N. (1971) Immune response of pigs to inactivated foot-and-mouth disease vaccines. Res. Vet. Sci. 12, 351-357
9. 9 Cunliffe H.R., Graves J.H. (1963) Formalin-treated foot-and-mouth disease virus: comparison of two adjuvants in cattle. Can. J. Comp. Med. Vet. Sci. 27, 193-197
10. 10 Adler E., Murillo P.A., Rivenson S. (1966) Vacunas oleasas preparacion de una emulsion estable tipo "aqua en aceite". Revista de Investigaciones Agropecuarias, Serie 4. Patol. Anim. Argentina 3, 1-14
11. 11 Graves J.H., McKercher P.D., Farris H.E. Jr., Cowan K.M. (1968) Early response of cattle and swine to inactivated foot-and-mouth disease vaccine. Res. Vet. Sci. 9, 35-40
12. 12 McKercher P.D., Farris H.E. Jr (1967) Foot-and-mouth disease in swine: response to inactivated vaccines. Arch. gesamte Virusforschung 22, 451-461
13. 13 McKercher P.D., Giordano A.R. (1967) Foot-and-mouth disease in swine. I. Immune response of swine to chemically treated and untreated foot-and-mouth disease virus. Arch. gesamte Virusforschung 20, 39-53
14. 14 McKercher P.D., Gailiunas P., Burrows R., Capstick P.B. (1971) Reaction of swine to oil-adjuvanted, inactivated foot-and-mouth disease virus vaccine inoculated by intramuscular and subcutaneous routes. Arch. gesamte Virusforschung 35, 364-377
15. 15 Dora J.F.P., Coelho Nunes J.C., Goulart da Silveira J.C., Jorgens E.N., Rosenberg F.J., Astudillo V.M. (1984) Epidemic of foot-and-mouth disease in Bage, RS, Brazil, 1980. Evaluation of two systems of vaccination. Bull. Centro Panamericano Fiebre Aftosa 49-50, 11-17
16. 16 Bahnemann H.G., Mesquita J.A. (1987) Oil-adjuvant vaccine against foot-and-mouth disease. Bull. Centro Panamericano Fiebre Aftosa 53, 25-30
17. 17 McKercher P.D., Graves J.H. (1977) A review of the current status of oil adjuvants in foot-and-mouth disease vaccines, International symposium on foot-and-mouth disease. Dev. Biol. Stand. 35, 107-112
18. 18 Barteling S.J., Vreeswijk J. (1991) Developments in foot-and-mouth disease vaccines. Vaccine 9, 75-88
19. 19 Doel T.R., Pullen L. (1990) International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them. Vaccine 8, 473-478
20. 20 Barteling, S.J., van Maanen, C., Yadin, H. and Anemaet, D.A.J. A foot-and-mouth disease vaccine bank: purified inactivated antigen stored at ultra-low temperatures for the rapid preparation of double oil emulsion (D.O.E.) vaccines. European Commission for the Control of Foot-and-Mouth Disease. Session of the Research Group of the Standing Technical Committee, Lindholm, 1990, pp. 172-177
21. 3 formulations. European Commission for the Control of Foot-and-Mouth Disease, Session of the Research Group of the Standing Technical Committee, Berne, 1992, pp. 25-29
22. 22 Cohrs P., Schultz F. (1952) Aluminiumhydroydgranulome bei Tieren. Zentralblatt allgemeine Pathol. pathol. Anat. 89, 77-82
23. 23 McKercher P.D., Gailiunas P. (1969) Response of swine to inactivated foot-and-mouth disease vaccines. Duration of Immunity and local tissue reactions. Arch. gesamte Virusforschung 28, 165-176
24. 24 Mussgay M., Wittmann G. (1968) Present position of research on the development of foot-and-mouth disease vaccine for pigs. Berliner Münchner tierärztliche Wochenschrift 81, 124-129
25. 25 Wittmann G., Bauer K. (1969) Oertliche reaktionen nach der impfung von schweinen mit maul-und klauenseuche (MKS)-vakzinen, die Freund'sches adjuvans enthalten. Berliner Münchner tierärztliche Wochenschrift 82, 2-4
26. 26 Anderson E.C., Masters R.C., Mowat G.N. (1971) Immune responses of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccines. Res. Vet. Sci. 12, 342-350
27. 27 Mowat G.N. (1972) Quantities of purified antigen required to immunize swine against foot-and-mouth disease. Bull. Off. Int. Epiz. 77, 887-897
28. 28 Casas Olascoaga R. (1978) Summary of current research of Pan American Foot-and-Mouth Disease Center on oil-adjuvanted vaccines. Bull. Off. Int. Epiz. 89, 1015-1054
29. 29 Gomes I., Sutmoller P., Casas Olascoaga R. (1980) Response of cattle to foot-and-mouth disease (FMD) virus exposure one year after immunization with oil-adjuvanted FMD vaccine. Bul. Centro Panamericano Fiebre Aftosa 37, 31-35
30. 30 Bahnemann, H., Mesquita, J., Astudillo, V. and Dora, F. Production and application of an oil adjuvant vaccine against foot-and-mouth disease in cattle. In: Modern Approaches to Animal Cell Technology (Eds Spier, R.E. and Griffith, J.B.). Butterworth, Guildford, 1988, Vol. 1, p. 628
31. 31 Ananda Rao K., Palanisamy R., Kalanidhi A.P., Azad H.M., Srinivasan V.A. (1993) Use of foot-and-mouth disease vaccine in cattle. Indian. Vet. J. 70, 493-497
32. 32 Späth E.J.A., Smitsaart E., Casaro A.P.E. (1995) Immune response of calves to foot-and-mouth disease virus, vaccine emulsified with oil adjuvants: strategies of vaccination. Vaccine 13, 909-914
33. 33 Hunter, P. The performance of SAT types of foot-and-mouth disease antigen in oil adjuvant vaccines. Scient. Technical Rev. OIE 1996, September 15
34. 34 Salt, J.S., Williams, L., Statham, R. and Barnett, P.V. Further studies on the rate of development of protection in cattle given emergency vaccination against FMD. European Commission for the Control of Foot-and-Mouth disease, Session of the Research Group of the Standing Technical Committee, Vienna, 1994, pp. 98-102
35. 35 Bomford R. (1989) Adjuvants for anti-parasite vaccines: a review. Parasit. Today 5, (2) 41-46